Medindia
Medindia LOGIN REGISTER
Advertisement

New Sealed Lighting with Indigo-Clean Disinfection Helps Pharmacies Meet USP 800 Requirements

Wednesday, December 4, 2019 Drug News
Advertisement
In order to help pharmacies meet the requirements for USP 800, targeted for implementation this month, Kenall is introducing the CSEDOIC luminaire series.
Advertisement

KENOSHA, Wis., Dec. 4, 2019 /PRNewswire-PRWeb/ -- In order to help pharmacies meet the requirements for USP 800, targeted for implementation this month, Kenall is introducing the CSEDOIC luminaire series. CSEDOIC fixtures are designed for cleanrooms, where air pressure must be tightly controlled. USP 800 now requires the unpacking of hazardous drugs (HDs) and HD-active pharmaceutical ingredients from the original container be done in neutral pressure or negative pressure rooms to reduce the risk of airborne contamination outside the pharmacy area – making sealed light fixtures critical to room design.
Advertisement

The CSEDOIC series also utilizes Indigo-Clean Visible Light Disinfection to kill harmful bacteria that may be inadvertently introduced into the cleanroom environment, accidentally contaminating sterile preparations. This unique new light fixture, pairing bacteria-killing technology with a sealed housing, is a cutting-edge way to meet and exceed USP 797 and 800 requirements in the healthcare space.

The fixture's dual-mode Indigo-Clean technology provides white ambient light with disinfection in occupied spaces, and switches automatically to full Indigo mode to maximize disinfection when the room is unoccupied. A dedicated occupancy sensing system assures proper mode control. "This is a completely unique product designed specifically for pharmacies that must now meet the demands of USP 797 and 800," said Tim Stevens, Kenall's product manager. "It addresses the needs of the pharmacy space and helps ensure patients receive quality pharmaceuticals, free from contaminants," he continued.

Indigo-Clean is a proven and patented technology that launched in 2015 to the healthcare industry. It is currently being used to disinfect operating rooms, emergency departments and other critical care areas in medical facilities across the United States. A July 2019 American Journal of Infection Control (AJIC) peer-reviewed study reported a bacterial reduction of more than 85%. The new light fixture is recommended for the following areas:

  • Hospital pharmacies
  • Compounding pharmacies
  • Anteroom pharmacies
About Kenall Indigo-Clean is a brand of Kenall Manufacturing, an independent sector of Legrand. Kenall was founded in Chicago, Illinois in 1963 and has built a reputation for durable lighting solutions of superior quality and exceptional value. Today, the company creates unique solutions for the healthcare, cleanroom/containment, food processing, transportation, high abuse, and correctional lighting markets. Kenall luminaires are designed in Kenosha, Wisconsin, and comply with the Buy American Act (manufactured in the United States with more than 50% of the component cost of US origin). For additional information, visit http://www.kenall.com.

About Legrand and Legrand, North and Central America Legrand is the global specialist in electrical and digital building infrastructures. Its comprehensive offering of solutions for use in commercial, industrial, and residential markets makes it a benchmark for customers worldwide. Legrand reported sales of approximately $7.1 billion (USD) in 2018. Legrand has a strong presence in North and Central America, with a portfolio of well-known market brands and product lines that includes AFCO Systems, C2G, Cablofil, Chief, Da-Lite, Electrorack, Finelite, Kenall, Luxul, Middle Atlantic Products, Milestone AV, Nuvo, OCL, On-Q, Ortronics, Pass & Seymour, Pinnacle, Projecta, QMotion, Quiktron, Raritan, Sanus, Server Technology, Solarfective, Vaddio, Vantage, Wattstopper, and Wiremold. Legrand is listed on Euronext Paris and is a component stock of indexes including the CAC40, http://www.legrand.us.

 

SOURCE Kenall

Sponsored Post and Backlink Submission


Latest Press Release on Drug News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close